期刊文献+

散发型Ⅰ型神经纤维瘤的基因突变鉴定与家系分析 被引量:2

Gene diagnosis and pedigree analysis in families of sporadic type Ⅰ neurofi broma family
原文传递
导出
摘要 目的对一例先证者为Ⅰ型神经纤维瘤病的患儿进行基因突变鉴定与家系研究。方法采用高通量测序技术对NF1基因进行点突变和基因拷贝数检测,应用MLPA技术对患者NF1、NF2基因进行大片段变异研究,采用STR连锁分析对先证者及其父母进行亲缘关系鉴定,对其父母进行体格检查和表型分析,采用Sanger测序方法对高通量测序点突变进行先证者和家系验证。结果高通量测序检出患者NF1基因致病变异c.1013A>G,该突变为已报道的Ⅰ型神经纤维瘤致病突变,其生物学父母未见神经纤维瘤表型且无上述突变。结论该神经纤维瘤患儿是由NF1新发突变所致,高通量测序技术对检测致病基因含较多外显子的遗传性疾病具有显著优势。 Objective:To identify the genetic ecology and family analyse a patient with neurofibromatosis type 1.Methods:High-throughput sequencing was used to detect the point mutation and copy number of NF1 and NF2 gene.MLPA was used to verify the large-segment mutation of NF1 and NF2 gene.STR linkage analysis was used to identify the relationship between the proband parents and their parents.Physical examination and phenotypic analysis,Sanger sequencing was used to analyze the point mutation of NF1 and NF2 gene in the parents.Results:High-throughput sequencing showed that the pathogenic mutation of NF1 gene was c.1013A>G.The mutation was a reported neurofibroma in type I pathogenic mutation.The biological parents had no neurofibroma phenotype and no NF1 gene mutation.Conclusion:The neurofibroma is caused by a new mutation in NF1,and high-throughput sequencing has a significant advantage in detecting genetic diseases with more exons in the pathogenic gene.
作者 畅荣妮 谭建强 潘莉珍 袁德健 蔡稔 CHANG Rong-ni;TAN Jian-qiang;PAN Li-zhen;YUAN De-jian;CAI Ren(Liuzhou Maternal and Child Health Care Hospital,Liuzhou,Guangxi 545000)
出处 《中国优生与遗传杂志》 2019年第1期19-21,24,共4页 Chinese Journal of Birth Health & Heredity
关键词 Ⅰ型神经纤维瘤 牛奶咖啡斑 错义突变 高通量测序 Neurofibromatosis type 1 Café-au-Lait Spots Missense mutation High-throughput sequencing
  • 相关文献

参考文献2

二级参考文献11

  • 1Friedman JM. Epidemiology of neurofibromatosis type [ J ]. Am J Med Genet, 1999,89: 1 - 6.
  • 2Wallace MR, Marchuk DA, Anderson LB,et al. Type 1 neurofibro - matosis gene : Identification of a large transcript disrupted in three pa- tients[ J ]. Science, 1990,249 ( 3 ) : 181 - 186.
  • 3Ars E,Kruyer H, Morell M,et al. Recurrent mutation in the NFI gene are common among neurofibromatosis typel patients[ J]. J Med Genet, 2003,40 (6) : 82.
  • 4Viskocchil DH, White R, Cawthon R. The neurofibromatosis type gene[J]. Ann Rev Neurosci, 1993, 16(2): 183.
  • 5Cawthon RM, Weiss R, Xu G, et al. A major segment to the neurofi- bromatosis type 1 gene: eDNA sequence, genomic strueture, and point mutations[J]. Ceil,1990, 62 (1) 193.
  • 6Lan Kluwe, Reinhard E Friedrich, Matthias Peiper, et al. Constitu- tional NFI Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors[ J]. Hum Mutat, 2003, 22 (5) : 1 - 5.
  • 7JJ Jonsson, MD Foresman, N Wilson, et al. Intron requirement for expression of the human purine nucleoside phosphorylase gene [ J ]. Nucleic Acids Res, 1992, 20(2): 3191 -3194.
  • 8MJ Stewart, G Cox, A Reife -1 Miller, et al. Anovel transcriptional sup - pressor located with in a down streamintron of the BCR gene [J]. Biol Chem, 1994, 269(3): 10820 - 10821.
  • 9Brooke L, Heidenfelder MD. Effectsof sequenceon repeat expansion during DNAreplication[ J]. Nucleic Acids Research, 2003, 31 (1) : 7159-7162.
  • 10Park VM, EK Pivnick. Neurofibromatosis type 1 ( NF1 ) : a protein truncation assay yielding identification of mutations in 73% of pa- tients[ J]. J Med Genet, 1998,35 (10) : 813 - 820.

共引文献7

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部